AK

Arvind Kumar Srivastava

Active Director Director DIN 10055464
DIN 10055464 First appointment Feb 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Arvind Kumar Srivastava

Data last updated:

Arvind Kumar Srivastava is a Director at Hekakare Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Hekakare Pharmaceuticals Private Limited reported revenue of ₹12,000 (FY 2025).

DIN 10055464
Primary Designation Director
Industry Pharma
First Appointment 24 Feb 2023
Oldest Company Age 3 yrs
Largest company Hekakare Pharmaceuticals Private Limited · ₹12,000 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Feb 20232023₹12,000 (FY 2025)Active

Board colleagues of Arvind Kumar Srivastava

NameDINCompanyDesignation
Hridesh Kumar10055465Hekakare Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hekakare Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arvind Kumar Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arvind Kumar Srivastava

Arvind Kumar Srivastava currently holds 1 directorship: Hekakare Pharmaceuticals Private Limited (Director, since 24 Feb 2023, revenue ₹12,000 (FY 2025)).

Arvind Kumar Srivastava was first appointed on 24 Feb 2023 as Director at Hekakare Pharmaceuticals Private Limited.

The current boards of Arvind Kumar Srivastava's companies include Hridesh Kumar (Hekakare Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available